|
Market Closed -
Nasdaq
00:00:00 31/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 15.19 USD | -0.52% |
|
+4.76% | - |
| 09-21 | Attovia Therapeutics, Inc.(NasdaqGM:ATTO) added to S&P TMI Index | CI |
| 09-16 | Attovia Therapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 10:00 AM |
Evolution of the Average Target: Attovia Therapeutics, Inc.
Evolution of the Target Price: Attovia Therapeutics, Inc.
Changes in Analyst Recommendations: Attovia Therapeutics, Inc.
96e6f3f87a898d40b4406add8.mLyGM0dddV8JikaWeJ-SUJY0ptuvhz3086Wu7jEQH9U.3_e0QyEoGDpF5iHsT8jbAMlf7a3L1X6cstT_2mRxaOPu2dZSJCs_BW_Ecg~033db840e11a7f187328484d3c102f79
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +176.36% | |||
| +41.6% | |||||
| +24.9% | |||||
| +8.71% | |||||
| +12.62% | |||||
| +17.47% | |||||
| +36.04% | |||||
| +1% | |||||
| +42.98% | |||||
| +33.85% | |||||
| Average | +39.55% | |||||
| Weighted average by Cap. | +24.58% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
15.27USD
Average target price
42.20USD
Spread / Average Target
+176.36%
High Price Target
52.00USD
Spread / Highest target
+240.54%
Low Price Target
30.00USD
Spread / Lowest Target
+96.46%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- ATTO Stock
- Consensus Attovia Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
